Related Experiment Videos
Henoch-Schönlein purpura
1Division of Pediatric Rheumatology, Childrens Hospital, Los Angeles, CA 90027.
Current Opinion in Rheumatology
|January 1, 1994
Summary
Henoch-Schönlein purpura (HSP), a common childhood vasculitis, typically presents with rash, abdominal pain, and blood in urine. While often self-limiting, its full spectrum and management require further research.
Area of Science:
- Pediatrics
- Rheumatology
- Immunology
Background:
- Henoch-Schönlein purpura (HSP) is the most prevalent vasculitis syndrome in children.
- It is characterized by a classic triad of purpuric rash, abdominal pain, and hematuria, though presentations vary widely.
- HSP is generally a benign, self-limited condition often following upper respiratory infections.
Purpose of the Study:
- To review recent advancements in understanding Henoch-Schönlein purpura (HSP).
- To highlight the expanding clinical spectrum and immunologic aspects of HSP.
- To address the ongoing debate regarding corticosteroid use in HSP management.
Main Methods:
- Literature review of recent clinical studies on Henoch-Schönlein purpura (HSP).
- Analysis of case reports detailing the diverse clinical manifestations of HSP.
- Summary of emerging research on the immunologic underpinnings of HSP.
Main Results:
- The clinical spectrum of HSP is broader than previously recognized, ranging from mild rash to severe organ involvement.
- Recent literature distinguishes HSP from other hypersensitivity vasculitides.
- Immunologic aspects of HSP are increasingly understood, though the role of antineutrophil cytoplasmic antibodies is still unclear.
Conclusions:
- Henoch-Schönlein purpura (HSP) exhibits a wide range of clinical presentations, necessitating careful diagnosis and monitoring.
- Further research is needed to clarify the etiology, pathogenesis, and optimal management strategies for HSP.
- The precise role of corticosteroids and other treatments in HSP requires further investigation.